{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T06:40:03Z","timestamp":1750920003926,"version":"3.41.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Background: Female patients with Peutz-Jeghers syndrome (PJS) have an increased risk of breast cancer (BrCa), and surveillance is recommended. However, clinicopathological features of their tumors and prognosis are lacking. To facilitate more precise future guideline development, we evaluated these data. Methods: We conducted an international survey for InSiGHT members to collect retrospective data on PJS patients with diagnosed breast cancer. Results: We received 23 responses, including three centers with data on BrCa patients. All reported BrCa patients were female. In total, the cohort comprised 27 patients with 34 BrCa (five bilateral synchronous, one bilateral metachronous, and one metachronous unilateral tumours). The median age at first cancer diagnosis was 45 years (range 26\u201367). Most cancers were ductal carcinoma, either invasive (13) or in situ (DCIS; 19). TNM staging for invasive cancer was available in thirteen cases, of which nine were T1N0M0. Among tumors with histological reports, 14\/15 were oestrogen receptor positive, 8\/15 were progesterone receptor positive, and 4\/15 were HER2 positive. There were no triple negative breast cancers. Twenty-five patients had follow-up data, comprising 229 patient years. Eleven patients had died of any cause during follow-up. Survival at 5 years was 73%. Conclusion: Overall, breast cancers that occur in this PJS population seem to have favorable characteristics and prognosis. These data will help inform discussions about risk management in patients with PJS. Further research is needed to better understand lifetime risk, the optimal surveillance modality and its outcomes.<\/jats:p>","DOI":"10.1007\/s10689-025-00469-5","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T10:28:53Z","timestamp":1746268133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinicopathological features of breast cancer in Peutz-Jeghers syndrome: results from an international survey"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1249-4442","authenticated-orcid":false,"given":"Elizabeth","family":"Loehrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-3876","authenticated-orcid":false,"given":"Anja","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massiah","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Rubab","family":"Ramzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-4517","authenticated-orcid":false,"given":"Anne Marie","family":"Jelsig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Goverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"van Leerdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E.","family":"Korsse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4363-0745","authenticated-orcid":false,"given":"Evelien","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-9757","authenticated-orcid":false,"given":"Manon C. W.","family":"Spaander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-0399","authenticated-orcid":false,"given":"John G\u00e1sdal","family":"Karstensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-5953","authenticated-orcid":false,"given":"Veronica","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-9678","authenticated-orcid":false,"given":"Finlay","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8626-188X","authenticated-orcid":false,"given":"Andrew","family":"Latchford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"issue":"1","key":"469_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0197-87","volume":"15","author":"A Hemminki","year":"1997","unstructured":"Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM et al (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15(1):87\u201390","journal-title":"Nat Genet"},{"issue":"6663","key":"469_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/34432","volume":"391","author":"A Hemminki","year":"1998","unstructured":"Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A et al (1998) A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391(6663):184\u2013187","journal-title":"Nature"},{"key":"469_CR3","first-page":"134","volume":"10","author":"JLA Peutz","year":"1921","unstructured":"Peutz JLA (1921) Over Een Zeer Merkwaardige, gecombineerde Familiaire polyposis Van de Slijmliezen Van Den tractus intestinalis Met die Van de Neuskeelholte En Gepaard Met eigenaardige pigmentaties Van huid-en Slijmvliezen. Nederl Maandschr Geneesk 10:134\u2013146","journal-title":"Nederl Maandschr Geneesk"},{"issue":"26","key":"469_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM194912292412601","volume":"241","author":"H Jeghers","year":"1949","unstructured":"Jeghers H, Mc KV, Katz KH (1949) Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 241(26):1031\u20131036","journal-title":"N Engl J Med"},{"issue":"7","key":"469_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/gut.2009.198499","volume":"59","author":"AD Beggs","year":"2010","unstructured":"Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59(7):975\u2013986","journal-title":"Gut"},{"issue":"5","key":"469_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00384-016-2560-3","volume":"31","author":"AM Jelsig","year":"2016","unstructured":"Jelsig AM, Qvist N, Sunde L, Brusgaard K, Hansen T, Wikman FP et al (2016) Disease pattern in Danish patients with Peutz-Jeghers syndrome. Int J Colorectal Dis 31(5):997\u20131004","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"469_CR7","first-page":"71","volume":"136","author":"J Utsunomiya","year":"1975","unstructured":"Utsunomiya J, Gocho H, Miyanaga T, Hamaguchi E, Kashimure A (1975) Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 136(2):71\u201382","journal-title":"Johns Hopkins Med J"},{"issue":"6","key":"469_CR8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/gast.2000.20228","volume":"119","author":"FM Giardiello","year":"2000","unstructured":"Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV et al (2000) Very high risk of cancer in Familial Peutz-Jeghers syndrome. Gastroenterology 119(6):1447\u20131453","journal-title":"Gastroenterology"},{"issue":"10","key":"469_CR9","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","volume":"12","author":"N Hearle","year":"2006","unstructured":"Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209\u20133215","journal-title":"Clin Cancer Res"},{"issue":"7","key":"469_CR10","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/gut.2005.082990","volume":"55","author":"H Mehenni","year":"2006","unstructured":"Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC (2006) Cancer risks in LKB1 germline mutation carriers. Gut 55(7):984\u2013990","journal-title":"Gut"},{"issue":"2","key":"469_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gut.2010.223750","volume":"60","author":"MG van Lier","year":"2011","unstructured":"van Lier MG, Westerman AM, Wagner A, Looman CW, Wilson JH, de Rooij FW et al (2011) High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut 60(2):141\u2013147","journal-title":"Gut"},{"issue":"7","key":"469_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.dld.2012.12.018","volume":"45","author":"N Resta","year":"2013","unstructured":"Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R et al (2013) Cancer risk associated with STK11\/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. Dig Liver Dis 45(7):606\u2013611","journal-title":"Dig Liver Dis"},{"issue":"11","key":"469_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00595-015-1296-y","volume":"46","author":"H Ishida","year":"2016","unstructured":"Ishida H, Tajima Y, Gonda T, Kumamoto K, Ishibashi K, Iwama T (2016) Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan. Surg Today 46(11):1231\u20131242","journal-title":"Surg Today"},{"issue":"6","key":"469_CR14","doi-asserted-by":"publisher","first-page":"101042831770513","DOI":"10.1177\/1010428317705131","volume":"39","author":"HY Chen","year":"2017","unstructured":"Chen HY, Jin XW, Li BR, Zhu M, Li J, Mao GP et al (2017) Cancer risk in patients with Peutz-Jeghers syndrome: A retrospective cohort study of 336 cases. Tumour Biol 39(6):1010428317705131","journal-title":"Tumour Biol"},{"issue":"6","key":"469_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1053\/j.gastro.2023.08.040","volume":"165","author":"AM Jelsig","year":"2023","unstructured":"Jelsig AM, Wullum L, Kuhlmann TP, Ousager LB, Burisch J, Karstensen JG (2023) Risk of Cancer and mortality in Peutz-Jeghers syndrome and juvenile polyposis syndrome-A nationwide cohort study with matched controls. Gastroenterology 165(6):1565\u20131567e2","journal-title":"Gastroenterology"},{"issue":"2","key":"469_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3904\/kjim.2022.208","volume":"38","author":"SH Kim","year":"2023","unstructured":"Kim SH, Kim ER, Park JJ, Kim ES, Goong HJ, Kim KO et al (2023) Cancer risk in patients with Peutz-Jeghers syndrome in Korea: a retrospective multi-center study. Korean J Intern Med 38(2):176\u2013185","journal-title":"Korean J Intern Med"},{"key":"469_CR17","doi-asserted-by":"crossref","unstructured":"Wagner A, Aretz S, Auranen A, Bruno MJ, Cavestro GM, Crosbie EJ et al (2021) The management of Peutz-Jeghers syndrome: European hereditary tumour group (EHTG) guideline. J Clin Med 10(3):473\u2013491","DOI":"10.3390\/jcm10030473"},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cancergen.2017.11.004","volume":"220","author":"F Fostira","year":"2018","unstructured":"Fostira F, Mollaki V, Lypas G, Alexandrakis G, Christianakis E, Tzouvala M et al (2018) Genetic analysis and clinical description of Greek patients with Peutz-Jeghers syndrome: creation of a National registry. Cancer Genet 220:19\u201323","journal-title":"Cancer Genet"},{"issue":"2","key":"469_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/eurpub\/cku088","volume":"25","author":"D van der Waal","year":"2015","unstructured":"van der Waal D, Verbeek AL, den Heeten GJ, Ripping TM, Tjan-Heijnen VC, Broeders MJ (2015) Breast cancer diagnosis and death in the Netherlands: a changing burden. Eur J Public Health 25(2):320\u2013324","journal-title":"Eur J Public Health"},{"key":"469_CR20","unstructured":"Cancer Statistics SEER, Review 1975\u20132017, National Cancer Institute [Internet]. Available from: https:\/\/seer.cancer.gov\/csr\/1975_2017\/"},{"key":"469_CR21","unstructured":"Lifetime risk estimates calculated by the Cancer Intelligence Team at Cancer Research UK [Internet] (2023) Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/risk-factors#ref-1"},{"key":"469_CR22","volume-title":"Breast tumours","author":"Board WCoTE","year":"2019","unstructured":"Board WCoTE (2019) Breast tumours, 5th edn. IARC, Lyon","edition":"5"},{"key":"469_CR23","unstructured":"Petrucelli NDMB, Pal T BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer Seattle (WA): University of Washington, Seattle: GeneReviews\u00ae [Internet]; 1998 [updated 2023 Sep 21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247\/"},{"key":"#cr-split#-469_CR24.1","unstructured":"Wu M, Krishnamurth K, Peutz-Jeghers Syndrome [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL):: StatPearls Publishing"},{"key":"#cr-split#-469_CR24.2","unstructured":"2023 [updated 2023 Jul 17. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535357\/"},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.maturitas.2017.08.004","volume":"105","author":"C Rousset-Jablonski","year":"2017","unstructured":"Rousset-Jablonski C, Gompel A (2017) Screening for Familial cancer risk: focus on breast cancer. Maturitas 105:69\u201377","journal-title":"Maturitas"},{"issue":"13","key":"469_CR26","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1158\/1078-0432.CCR-17-0790","volume":"23","author":"MI Achatz","year":"2017","unstructured":"Achatz MI, Porter CC, Brugieres L, Druker H, Frebourg T, Foulkes WD et al (2017) Cancer screening recommendations and clinical management of inherited Gastrointestinal Cancer syndromes in childhood. Clin Cancer Res 23(13):e107\u2013e14","journal-title":"Clin Cancer Res"},{"key":"469_CR27","doi-asserted-by":"crossref","unstructured":"Klimkowski S, Ibrahim M, Ibarra Rovira JJ, Elshikh M, Javadi S, Klekers AR et al (2021) Peutz-Jeghers syndrome and the role of imaging: pathophysiology, diagnosis, and associated cancers. Cancers (Basel) 13(20):5121","DOI":"10.3390\/cancers13205121"},{"key":"#cr-split#-469_CR28.1","unstructured":"Government N (2010) STK11 (Peutz-Jeghers) - risk management: eviQ, Cancer Institute NSW"},{"key":"#cr-split#-469_CR28.2","unstructured":"[updated 5 July 2022. Available from: https:\/\/www.eviq.org.au\/cancer-genetics\/adult\/risk-management\/395-stk11-peutz-jeghers-risk-management#cancer-tumour-risk-management-guidelines"},{"issue":"1","key":"469_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/his.14808","volume":"82","author":"A Sokolova","year":"2023","unstructured":"Sokolova A, Johnstone KJ, McCart Reed AE, Simpson PT, Lakhani SR (2023) Hereditary breast cancer: syndromes, tumour pathology and molecular testing. Histopathology 82(1):70\u201382","journal-title":"Histopathology"},{"issue":"9","key":"469_CR30","first-page":"511","volume":"160","author":"B Martin-Odegard","year":"1994","unstructured":"Martin-Odegard B, Svane S (1994) Peutz-Jeghers syndrome associated with bilateral synchronous breast carcinoma in a 30-year-old woman. Eur J Surg 160(9):511\u2013512","journal-title":"Eur J Surg"},{"issue":"2","key":"469_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF01317062","volume":"29","author":"PA Lehur","year":"1984","unstructured":"Lehur PA, Madarnas P, Devroede G, Perey BJ, Menard DB, Hamade N (1984) Peutz-Jeghers syndrome. Association of duodenal and bilateral breast cancers in the same patient. Dig Dis Sci 29(2):178\u2013182","journal-title":"Dig Dis Sci"},{"issue":"4","key":"469_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/1097-0142(19820815)50:4<788::AID-CNCR2820500428>3.0.CO;2-D","volume":"50","author":"H Trau","year":"1982","unstructured":"Trau H, Schewach-Millet M, Fisher BK, Tsur H (1982) Peutz-Jeghers syndrome and bilateral breast carcinoma. Cancer 50(4):788\u2013792","journal-title":"Cancer"},{"issue":"4","key":"469_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/1097-0142(19800815)46:4<815::AID-CNCR2820460428>3.0.CO;2-V","volume":"46","author":"E Riley","year":"1980","unstructured":"Riley E, Swift M (1980) A family with Peutz-Jeghers syndrome and bilateral breast cancer. Cancer 46(4):815\u2013817","journal-title":"Cancer"},{"issue":"11","key":"469_CR34","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/hmg\/ddz027","volume":"28","author":"A Lipsa","year":"2019","unstructured":"Lipsa A, Kowtal P, Sarin R (2019) Novel germline STK11 variants and breast cancer phenotype identified in an Indian cohort of Peutz-Jeghers syndrome. Hum Mol Genet 28(11):1885\u20131893","journal-title":"Hum Mol Genet"},{"issue":"1","key":"469_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00404-007-0535-x","volume":"278","author":"T Kilic-Okman","year":"2008","unstructured":"Kilic-Okman T, Yardim T, Gucer F, Altaner S, Yuce MA (2008) Breast cancer, ovarian gonadoblastoma and cervical cancer in a patient with Peutz-Jeghers syndrome. Arch Gynecol Obstet 278(1):75\u201377","journal-title":"Arch Gynecol Obstet"},{"issue":"5\u20136","key":"469_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1159\/000082933","volume":"67","author":"C Nakanishi","year":"2004","unstructured":"Nakanishi C, Yamaguchi T, Iijima T, Saji S, Toi M, Mori T et al (2004) Germline mutation of the LKB1\/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome. Oncology 67(5\u20136):476\u2013479","journal-title":"Oncology"},{"issue":"Suppl 1","key":"469_CR37","first-page":"1","volume":"18","author":"International society for gastrointestinal hereditary tumours-InSiGHT","year":"2019","unstructured":"International society for gastrointestinal hereditary tumours-InSiGHT (2019) Fam Cancer 18(Suppl 1):1\u201388","journal-title":"Fam Cancer"},{"issue":"1","key":"469_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10689-007-9159-3","volume":"7","author":"PM Lynch","year":"2008","unstructured":"Lynch PM (2008) Standards of care in diagnosis and testing for hereditary colon cancer. Fam Cancer 7(1):65\u201372","journal-title":"Fam Cancer"},{"issue":"5","key":"469_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1399-0004.2006.00704.x","volume":"70","author":"E Chow","year":"2006","unstructured":"Chow E, Meldrum CJ, Crooks R, Macrae F, Spigelman AD, Scott RJ (2006) An updated mutation spectrum in an Australian series of PJS patients provides further evidence for only one gene locus. Clin Genet 70(5):409\u2013414","journal-title":"Clin Genet"},{"issue":"23","key":"469_CR40","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of breast, ovarian, and contralateral breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416","journal-title":"JAMA"},{"issue":"2","key":"469_CR41","first-page":"123","volume":"85","author":"FA Rodriguez Lagos","year":"2020","unstructured":"Rodriguez Lagos FA, Sorli Guerola JV, Romero Martinez IM, Codoner Franch P (2020) Register and clinical follow-up of patients with Peutz-Jeghers syndrome in Valencia registro y Seguimiento clinico de Pacientes Con sindrome de Peutz Jeghers En Valencia. Rev Gastroenterol Mex (Engl Ed) 85(2):123\u2013139","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"key":"469_CR42","volume-title":"Breast Cancer [Internet]","author":"E Orrantia-Borunda","year":"2022","unstructured":"Orrantia-Borunda E, A-NP, Acu\u00f1a-Aguilar LE et al (2022) Subtypes of breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3."},{"issue":"2","key":"469_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","volume":"161","author":"X Li","year":"2017","unstructured":"Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC et al (2017) Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat 161(2):279\u2013287","journal-title":"Breast Cancer Res Treat"},{"key":"469_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fphar.2018.00909","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Wu J, Zhang Z, Tang Y, Li X, Liu S et al (2018) Association between BRCA status and Triple-Negative breast cancer: A Meta-Analysis. Front Pharmacol 9:909","journal-title":"Front Pharmacol"},{"key":"469_CR45","unstructured":"SEER Cancer Stat Facts: Female Breast Cancer Subtypes National Cancer Institute; [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/breast-subtypes.html"},{"issue":"4","key":"469_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES et al (2019) Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer 121(4):285\u2013292","journal-title":"Br J Cancer"},{"key":"469_CR47","doi-asserted-by":"crossref","unstructured":"Salvatorelli L, Puzzo L, Vecchio GM, Caltabiano R, Virzi V, Magro G (2020) Ductal carcinoma in situ of the breast: an update with emphasis on radiological and morphological features as predictive prognostic factors. Cancers (Basel) 12(3):609","DOI":"10.3390\/cancers12030609"},{"issue":"5","key":"469_CR48","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","volume":"124","author":"AM Shaaban","year":"2021","unstructured":"Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG et al (2021) Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project. Br J Cancer 124(5):1009\u20131017","journal-title":"Br J Cancer"},{"issue":"6","key":"469_CR49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","volume":"54","author":"EH Lips","year":"2022","unstructured":"Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A et al (2022) Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat Genet 54(6):850\u2013860","journal-title":"Nat Genet"},{"key":"469_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","volume":"101","author":"AM Thompson","year":"2018","unstructured":"Thompson AM, Clements K, Cheung S, Pinder SE, Lawrence G, Sawyer E et al (2018) Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane project. Eur J Cancer 101:210\u2013219","journal-title":"Eur J Cancer"},{"issue":"3","key":"469_CR51","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-016-3973-y","volume":"159","author":"LE Elshof","year":"2016","unstructured":"Elshof LE, Schaapveld M, Schmidt MK, Rutgers EJ, van Leeuwen FE, Wesseling J (2016) Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Breast Cancer Res Treat 159(3):553\u2013563","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"469_CR52","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103(12):2481\u20132484","journal-title":"Cancer"},{"issue":"5","key":"469_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/modpathol.2014.141","volume":"28","author":"ME Sanders","year":"2015","unstructured":"Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD (2015) Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol 28(5):662\u2013669","journal-title":"Mod Pathol"},{"issue":"6","key":"469_CR54","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/JCO.2005.04.0345","volume":"25","author":"ES Hwang","year":"2007","unstructured":"Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL (2007) Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol 25(6):642\u2013647","journal-title":"J Clin Oncol"},{"issue":"1","key":"469_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","volume":"18","author":"PA van Luijt","year":"2016","unstructured":"van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J et al (2016) The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res 18(1):47","journal-title":"Breast Cancer Res"},{"issue":"9","key":"469_CR56","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser MD, Weaver DL, Zhao F, Worni M, Grimm LJ, Gulati R et al (2019) Cancer outcomes in DCIS patients without locoregional treatment. J Natl Cancer Inst 111(9):952\u2013960","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"469_CR57","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer 51(12):1497\u20131510","journal-title":"Eur J Cancer"},{"key":"469_CR58","unstructured":"Field K, Phillips K-A (2007) Management of women at high familial risk of breast and ovarian cancer. Cancer Forum 31:141\u2013149"},{"key":"469_CR59","doi-asserted-by":"crossref","unstructured":"Baranska A, Kanadys W (2022) Oral contraceptive use and breast Cancer risk for BRCA1 and BRCA2 mutation carriers: systematic review and Meta-Analysis of Case-Control studies. Cancers (Basel) 14(19):4774","DOI":"10.3390\/cancers14194774"},{"key":"469_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.02.007","volume":"148","author":"R Michaelson-Cohen","year":"2021","unstructured":"Michaelson-Cohen R, Gabizon-Peretz S, Armon S, Srebnik-Moshe N, Mor P, Tomer A et al (2021) Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy. Eur J Cancer 148:95\u2013102","journal-title":"Eur J Cancer"},{"issue":"7","key":"469_CR61","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00432-021-03629-z","volume":"147","author":"D Huber","year":"2021","unstructured":"Huber D, Seitz S, Kast K, Emons G, Ortmann O (2021) Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review. J Cancer Res Clin Oncol 147(7):2035\u20132045","journal-title":"J Cancer Res Clin Oncol"},{"issue":"23","key":"469_CR62","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","volume":"377","author":"LS Morch","year":"2017","unstructured":"Morch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard O (2017) Contemporary hormonal contraception and the risk of breast Cancer. N Engl J Med 377(23):2228\u20132239","journal-title":"N Engl J Med"},{"issue":"6","key":"469_CR63","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ajog.2021.12.022","volume":"226","author":"NA Burchardt","year":"2022","unstructured":"Burchardt NA, Eliassen AH, Shafrir AL, Rosner B, Tamimi RM, Kaaks R et al (2022) Oral contraceptive use by formulation and breast cancer risk by subtype in the nurses\u2019 health study II: a prospective cohort study. Am J Obstet Gynecol 226(6):821 e1- e26","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"469_CR64","doi-asserted-by":"publisher","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","volume":"11","author":"E Roura","year":"2016","unstructured":"Roura E, Travier N, Waterboer T, de Sanjose S, Bosch FX, Pawlita M et al (2016) The influence of hormonal factors on the risk of developing cervical Cancer and Pre-Cancer: results from the EPIC cohort. PLoS ONE 11(1):e0147029","journal-title":"PLoS ONE"},{"issue":"9599","key":"469_CR65","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"C Cervical","year":"2007","unstructured":"International Collaboration of Epidemiological Studies of, Cervical C, Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S et al (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370(9599):1609\u20131621","journal-title":"Lancet"},{"issue":"7","key":"469_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.6004\/jnccn.2015.0105","volume":"13","author":"TB Bevers","year":"2015","unstructured":"Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB et al (2015) Breast Cancer risk reduction, version 2.2015. J Natl Compr Canc Netw 13(7):880\u2013915","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"469_CR67","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, Dunn B et al (2011) Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 12(5):496\u2013503","journal-title":"Lancet Oncol"},{"issue":"33","key":"469_CR68","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.19.01472","volume":"37","author":"K Visvanathan","year":"2019","unstructured":"Visvanathan K, Fabian CJ, Bantug E, Brewster AM, Davidson NE, DeCensi A et al (2019) Use of endocrine therapy for breast Cancer risk reduction: ASCO clinical practice guideline update. J Clin Oncol 37(33):3152\u20133165","journal-title":"J Clin Oncol"},{"issue":"18","key":"469_CR69","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National surgical adjuvant breast and bowel project (NSABP-P1) breast Cancer prevention trial. JAMA 286(18):2251\u20132256","journal-title":"JAMA"},{"issue":"5","key":"469_CR70","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1053\/j.seminoncol.2016.10.001","volume":"43","author":"EF Cobain","year":"2016","unstructured":"Cobain EF, Milliron KJ, Merajver SD (2016) Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol 43(5):528\u2013535","journal-title":"Semin Oncol"},{"issue":"9922","key":"469_CR71","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S et al (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 383(9922):1041\u20131048","journal-title":"Lancet"},{"issue":"18","key":"469_CR72","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","volume":"28","author":"ME Ropka","year":"2010","unstructured":"Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28(18):3090\u20133095","journal-title":"J Clin Oncol"},{"issue":"4","key":"469_CR73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/annonc\/mdv590","volume":"27","author":"SG Smith","year":"2016","unstructured":"Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS et al (2016) Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol 27(4):575\u2013590","journal-title":"Ann Oncol"},{"issue":"8630","key":"469_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"1","author":"T Fornander","year":"1989","unstructured":"Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C et al (1989) Adjuvant Tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1(8630):117\u2013120","journal-title":"Lancet"},{"issue":"25","key":"469_CR75","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2007.14.0921","volume":"26","author":"A DeMichele","year":"2008","unstructured":"DeMichele A, Troxel AB, Berlin JA, Weber AL, Bunin GR, Turzo E et al (2008) Impact of raloxifene or Tamoxifen use on endometrial cancer risk: a population-based case-control study. J Clin Oncol 26(25):4151\u20134159","journal-title":"J Clin Oncol"},{"issue":"9","key":"469_CR76","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/jama.2019.11885","volume":"322","author":"USPST Force","year":"2019","unstructured":"Force USPST, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M et al (2019) Medication use to reduce risk of breast cancer: US preventive services task force recommendation statement. JAMA 322(9):857\u2013867","journal-title":"JAMA"},{"issue":"1","key":"469_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","volume":"34","author":"C Sessa","year":"2023","unstructured":"Sessa C, Balmana J, Bober SL, Cardoso MJ, Colombo N, Curigliano G et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline. Ann Oncol 34(1):33\u201347","journal-title":"Ann Oncol"},{"issue":"8","key":"469_CR78","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/cncr.32715","volume":"126","author":"AE Weidner","year":"2020","unstructured":"Weidner AE, Liggin ME, Zuniga BI, Tezak AL, Wiesner GL, Pal T (2020) Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers. Cancer 126(8):1651\u20131655","journal-title":"Cancer"},{"issue":"23","key":"469_CR79","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1200\/JCO.20.01992","volume":"39","author":"C Gao","year":"2021","unstructured":"Gao C, Polley EC, Hart SN, Huang H, Hu C, Gnanaolivu R et al (2021) Risk of breast Cancer among carriers of pathogenic variants in breast Cancer predisposition genes varies by polygenic risk score. J Clin Oncol 39(23):2564\u20132573","journal-title":"J Clin Oncol"},{"issue":"34","key":"469_CR80","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1200\/JCO.2010.34.4440","volume":"29","author":"AW Kurian","year":"2011","unstructured":"Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW et al (2011) Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the breast Cancer family registry. J Clin Oncol 29(34):4505\u20134509","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00469-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00469-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T06:02:57Z","timestamp":1750917777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00469-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":82,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00469-5","relation":{},"ISSN":["1573-7292"],"issn-type":[{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}